Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: ETF
  • Objective: Health Care
  • Asset Class: Equity
  • Geographic Focus: U.S.

Powershares Dynamic Biotechnology & Genome Portfolio

+ Add to Watchlist

PBE:US

57.8100 USD 0.2900 0.50%

As of 20:04:06 ET on 05/28/2015.

Snapshot for Powershares Dynamic Biotechnology & Genome Portfolio (PBE)

Open: 57.8300 High - Low: 57.8399 - 57.2340 Primary Exchange: NYSE Arca
Volume: 14,886 52-Week Range: 38.6500 - 59.9800 Beta vs DZOTR: 1.0023

ETF Chart for PBE

No chart data available.
  • PBE:US 57.8100
  • 1D
  • 1M
  • 1Y
58.1000
Interactive PBE Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for PBE

PowerShares Dynamic Biotechnology & Genome Portfolio is an exchange-traded fund incorporated in the USA. The Fund seeks investment results that correspond to the price and yield of the Dynamic Biotechnology & Genome Intellidex Index, a fundamentally-weighted index. Securities shown to possess the greatest capital appreciation potential are selected by the Index.

Inception Date: 2005-06-23 Telephone: 1-800-983-0903
Managers: PETER HUBBARD / MICHAEL JEANETTE
Web Site: www.powershares.com

Fundamentals for PBE

NAV (on 2015-05-28) 57.8218
Assets (M) (on 2015-05-28) 557.9796
Shares out (M) 9.65
Market Cap (M) 557.87
% Premium -0.02
Average 52-Week % Premium 0.0023
Fund Leveraged N

Dividends for PBE

Dividend Type Omitted
Dividend Frequency Quarter
Last Dividend Net -
Dividend Yield (ttm) 0.48%

Performance for PBE

1-Month +4.96% 1-Year +47.23%
3-Month +5.45% 3-Year +38.41%
Year To Date +15.16% 5-Year +26.41%
Expense Ratio 0.63

Top Fund Holdings for PBE

Filing Date: 05/27/2015
Name Position Value % of Total
Meta Financial Group Inc 18,579,220 774,381,890 58.834%
Regeneron Pharmaceuticals Inc 63,673 32,815,154 2.493%
BioMarin Pharmaceutical Inc 246,102 31,880,053 2.422%
Gilead Sciences Inc 254,517 28,622,982 2.175%
Vertex Pharmaceuticals Inc 220,633 28,196,897 2.142%
Amgen Inc 167,069 26,804,550 2.036%
Biogen Inc 64,333 25,921,052 1.969%
Dyax Corp 951,211 25,416,358 1.931%
Alexion Pharmaceuticals Inc 146,089 24,560,483 1.866%
Repligen Corp 559,036 22,573,874 1.715%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil